07:00 , Sep 28, 2009 |  BC Week In Review  |  Company News

ImmuneRegen, Azopharma Product Development Group deal

The companies signed a letter of intent for CRO Azopharma to perform manufacturing, formulation development, preclinical toxicology and pharmacology studies of ImmuneRegen's Homspera . The analog of the naturally occurring immunomodulator substance P is in...